Tag:

diabetes

Latest Headlines

Latest Headlines

Lilly adds new Coco the Type 1 monkey tale to its Disney bookshelf

With a couple of meds for Type 1 diabetes--the type that's usually diagnosed in children and young adults--in its lineup, Eli Lilly has a vested interest in helping children and their parents understand the disease. And on that front, it's just released a new book to add to a growing collection of kid-friendly materials.

J&J lags in spine, trauma, diabetes and vision care but strong in electrophysiology, biosurgery

Medical devices continue to drag down Johnson & Johnson revenue growth, prompting executives to spend copious time analyzing the company's relative strengths in the segment on its latest earnings call.

China's Wuzhou says it will take 10% stake in oral insulin specialist Oramed for $52M

China's Guangxi Wuzhou Zhongheng Group disclosed that it intends to purchase a 10% stake in Israeli pharma company Oramed for $52 million, in return for exclusive Chinese distribution rights to its oral insulin following regulatory approval, according to a briefing from Reuters.

Analysts: Roche sale of diabetes diagnostics unit could be a long time coming

After Bayer offloaded its diabetes device unit last month, some investors thought Roche would follow suit and sell its own underperforming diabetes diagnostics business. The Swiss drugmaker has experienced its fair share of problems with the unit, which stalled recently in light of price cuts and reimbursement issues in the U.S. But anyone expecting a sale of Roche's diabetes diagnostics business shouldn't hold their breath, analysts said.

Cue the screaming fans: Nick Jonas signs up with Dexcom diabetes effort

It's a good time to be Dexcom. In the past year, the company has chalked up multiple approvals for its continuous glucose monitoring (CGM) device. And it's picked a young star with Type 1 diabetes to sing all about it.

ADA: Nasal powder and artificial pancreas with glucagon both show potential

Two new studies presented at the annual American Diabetes Association have shown the benefits of the hormone glucagon--used to control the concentration of glucose in the bloodstream--in patients with Type 1 diabetes. One is a nasal powder to treat hypoglycemia in children and the other is an advance in the development of an effective artificial pancreas, finding the addition of glucagon could reduce nighttime hypoglycemia.

Study: Researchers find dual-hormone artificial pancreas best for treating nocturnal hypoglycemia

Canadian researchers have found that the dual-hormone artificial pancreas works best for treating patients with Type 1 diabetes by reducing the amount of time they are exposed to nocturnal hypoglycemia.

Massachusetts General Hospital pits BCG vaccine against Type I diabetes in Ph II

Another indication may be on the horizon for the generic BCG vaccine as Massachusetts General Hospital got an OK from the FDA for a Phase II trial of the vaccine's ability to help patients with Type I diabetes.

KKR-backed Panasonic Healthcare to buy Bayer diabetes device biz for almost $1.2B

The long-rumored sale of Bayer's diabetes device business to Panasonic Healthcare looks like it's finally coming to fruition after speculation stretching back at least to early this year. Bayer has said it will sell its Diabetes Care business to Panasonic Healthcare for €1.022 billion ($1.16 billion) in a deal expected to close during the first quarter of next year.

Intarcia readies for FDA in 2016 as it reports detailed Phase III data for once-yearly diabetes implant

Intarcia expects to report Phase III data during the second half of 2015 for the remaining two of its four pivotal trials in its program for once-yearly exenatide implant ITCA 650. If all goes well, it plans to head to the FDA next year. This week, the company offered detailed results at the American Diabetes Association (ADA) conference in Boston from June 5-8 for its two Phase III trials that had already reported data in October 2014.